Morgan Stanley
RGDX

Morgan Stanley’s RESPONSE GENETICS, INC COMMON SHS (DELAWARE) RGDX Stock Holding History

Morgan Stanley’s Portfolio RGDX Stock Details RGDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-66
Closed – – 7010
2015
Q2 		$0 Buy
66
+1
+2% – ﹤0.01% 6936
2015
Q1 		$0 Hold
65
– – ﹤0.01% 6841
2014
Q4 		$0 Hold
65
– – ﹤0.01% 6844
2014
Q3 		$0 Hold
65
– – ﹤0.01% 6803
2014
Q2 		$0 Hold
65
– – ﹤0.01% 6726
2014
Q1 		$0 Buy
+65
New +$91 ﹤0.01% 6666

Morgan Stanley's RGDX Position: Q3 2015 in Review

Morgan Stanley sold out of RESPONSE GENETICS, INC COMMON SHS (DELAWARE) (RGDX) in Q3 2015, closing a stake of 66 shares.

Morgan Stanley first reported a position in RGDX in Q1 2014 and held it in 6 quarters. The position peaked at $0 in Q2 2015. 1 fund tracked by Wall St. Rank holds RGDX as of Q3 2015.

  • Morgan Stanley reported no remaining RESPONSE GENETICS, INC COMMON SHS (DELAWARE) position as of Q3 2015 after selling out during the quarter.
  • Morgan Stanley sold 66 RESPONSE GENETICS, INC COMMON SHS (DELAWARE) shares in Q3 2015.
  • Morgan Stanley first reported a position in RESPONSE GENETICS, INC COMMON SHS (DELAWARE) in Q1 2014 and held it in 6 quarters.
  • Morgan Stanley's RESPONSE GENETICS, INC COMMON SHS (DELAWARE) position peaked at $0 in Q2 2015.
  • 1 fund tracked by Wall St. Rank held RESPONSE GENETICS, INC COMMON SHS (DELAWARE) as of Q3 2015.

Based on Morgan Stanley's 13F filing for Q3 2015, filed 9 Nov 2015.